Nanotechnology Platforms for Antiviral Challenges: Fundamentals, Applications and Advances

Nanomaterials have the potential to be used as antiviral agents, and their upscaling from laboratory to fabrication stage is discussed. Nanocurcumin, silver nanoparticles, and carbon nanoparticles are highlighted for their biomedical applications, particularly in combating viral infections and pandemics. The role of nanotechnology in effectively combating viral infections and pandemics is emphasized, with case studies of specific pharma companies.

Format: Hardback
Length: 164 pages
Publication date: 08 February 2023
Publisher: Taylor & Francis Ltd

Nanomaterials have emerged as promising agents in the fight against viral infections and pandemics, offering a wide range of theoretical and practical applications. In this comprehensive review, we explore the theory and practical applications of nanomaterials as antiviral agents. We also delve into the upscaling of nanomaterials from the laboratory to the fabrication stage, highlighting key challenges and strategies.

Furthermore, we illustrate the use of nanocurcumin, silver nanoparticles, and carbon nanoparticles for biomedical applications, emphasizing their potential in treating viral infections and diseases. We also highlight the crucial role of nanotechnology in effectively combating viral infections and pandemics, with a particular focus on case studies of specific pharma companies.

Nanomaterials have the unique ability to target and disrupt viral replication mechanisms, making them highly effective in the treatment of viral infections. Their small size and surface properties allow them to penetrate cells and target specific viral proteins or genetic material. Additionally, nanomaterials can be designed to release antiviral agents in a controlled manner, ensuring targeted treatment and minimizing side effects.

One of the most promising applications of nanomaterials as antiviral agents is in the treatment of COVID-19. Nanocurcumin, a natural compound found in turmeric, has been shown to have antiviral properties against SARS-CoV-2, the virus responsible for COVID-19. Silver nanoparticles have also been explored for their antiviral effects, with some studies suggesting that they can inhibit the replication of the virus. Carbon nanoparticles, on the other hand, have been shown to have antimicrobial properties and can be used to kill bacteria and viruses.

In addition to their antiviral properties, nanomaterials can also be used to enhance the effectiveness of existing antiviral drugs. For example, silver nanoparticles can be used to enhance the delivery of antiviral drugs to infected cells, while nanocurcumin can be used to improve the immune response against viral infections.

However, the upscaling of nanomaterials from the laboratory to the fabrication stage presents several challenges. One of the main challenges is the control of their size, shape, and surface properties, which can affect their efficacy and safety. Additionally, the production of nanomaterials can be expensive and requires specialized equipment and expertise.

Despite these challenges, there are ongoing efforts to develop scalable and cost-effective production processes for nanomaterials. One approach is to use natural materials, such as plant-based compounds, which are less expensive and easier to produce. Another approach is to develop hybrid nanomaterials, which combine the benefits of different materials to achieve enhanced properties.

In conclusion, nanomaterials have the potential to revolutionize the treatment of viral infections and pandemics. Their unique properties and ability to target and disrupt viral replication mechanisms make them highly effective in the treatment of COVID-19 and other viral infections. However, the upscaling of nanomaterials from the laboratory to the fabrication stage presents several challenges, which require ongoing research and development. By developing scalable and cost-effective production processes, we can ensure that nanomaterials reach their full potential in the fight against viral infections and pandemics.

Weight: 490g
Dimension: 234 x 156 (mm)
ISBN-13: 9781032152301